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ABSTRACT  
The anti-inflammatory effects of the investigated compounds; Isoniazid, hydrazone, and Indomethacin were evaluated in this study. The 
experiment was performed using xylene induced topical ear edema method in mice model, at the dose of (0.5 mg/ear). Results showed that the 
compounds; Isoniazid, hydrazone, and Indomethacin exerted 85, 90 and 89% of inhibition percentages, respectively. The effect of hydrazone 
was statistically similar to the effect of indomethacin which is a standard anti-inflammatory drug. 
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Inflammation is a physiological defense of the body against 
aggression that results in tissue damage. It can be triggered 
by trauma, burns, radiation or the penetration of external 
pathogens (viruses, bacteria, parasites, antigens) 1. This 
complex response mainly mediated by two enzymes: 
cyclooxygenase and lipoxygenase that generate 
prostaglandins and leukotrienes respectively 2. Two stages of 
inflammation exist, acute and chronic inflammation. Acute 
inflammation is an initial stage of inflammation (innate 
immunity), which is mediated by activation of the immune 
system 3. If the inflammation lasts for a long time, the second 
stage of inflammation or chronic inflammation sets in and 
may predispose the host to various chronic diseases, 
including cancer 4. The primary function of inflammation is 
to eliminate the aggressor and allow tissue repair 5. As a 
result, the search for new substances with anti-inflammatory 
activities is very useful for improving human health, while 
avoiding the adverse effects of existing drugs. In this context 
is part of this research work whose main objective is to 
verify the anti-inflammatory activity of a new molecule; 4-
chloro-3-nitrobenzylidene) isonicotinohydrazide and 
compared with both drugs; indomethacin, and isoniazid 


















Scheme 1. Chemical structure of Isoniazid and hydrazone 
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Indomethacin  
Scheme 1. Chemical structure of Indomethacin 
The topical anti-inflammatory activity of this bioactive 
substance was performed using Xylene induced topical ear 
edema method in mice model.    
MATERIALS AND METHODS 
All chemicals and reagents used throughout this study were 
obtained from commercial sources and used without further 
purification; Isoniazid (BHD chemicals Ltd Poole England), 
indomethacin, Xylene (Sigma).  
Experimental animals 
Experiments were performed using young female Swiss 
albino mice and weighing 25-30 g. They were obtained from 
Pasteur institut (Algeria) and housed in plastic cages under 
normal laboratory conditions (12 h light / dark cycle, 23 ± 2 
°C) for an acclimatization period of 7 days prior to the 
experiments. All the animals were given food and water ad 
libitum.  
Xylene-induced ear edema in mice 
Adult albino female’s mice (25-30g) were randomised into 
different groups of 6 mice each were used for the 
experiment. The investigated compounds (0.5 mg/ear 
edema), were topically applied to various groups. 
Inflammation was induced in mice by topical application of 
30 µl of xylene and 30 µl of different synthetic product at the 
inner surface of the right ear. The thickness of the ear is 
measured before and half hour after the induction of 
inflammation by a digital caliper. The difference in thickness 
before and after the application of xylene is calculated 6. 
RESULTS AND DISCUSSION  
Xylene induced topical ear edema 
Xylene-induced ear edema in mice, is a model of acute 
inflammation, was used to evaluate the anti-edematous effect 
of the investigated hydrazone and the anti-tubercular drug; 
isoniazid and the anti-inflammatory drug; indomethacin. 
Xylene-induced ear edema is a reproducible experimental 
model and concedes a good predictive value for the 
screening of anti-inflammatory agents. The application of 
xylene on the ear induces fluid accumulation leading to the 
formation of edema which is characteristic of acute 
inflammation7. The difference in the thickness of the ear of 
the mice before and half an hour after the local application of 
xylene was used in the present study to evaluate the anti-
edema effect of the investigated compounds.  
Results showed that the compounds; Isoniazid, hydrazone, 
and Indomethacin exerted 85, 90 and 89% of inhibition 
percentages, respectively (Figure 1). The effect of hydrazone 
was statistically similar to the effect of indomethacin which 
is a standard anti-inflammatory drug. 
In literature, molecular and cellular mechanism by which 
xylene induces inflammation involves capsaicin-sensitive 
sensory neurons that, following stimulation, release a 
number of mediators that can initiate the inflammatory 
response8. In addition, the mechanism of action of 
indomethacin on inflammation is based on the inhibition of 
pro-inflammatory prostaglandin synthesis9. From these 
results we can conclude that the hydrazone could be an 




Figure 1. topical anti-inflammatory activity of hydrazone, indomethacin, and isoniazid  
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CONCLUSIONS  
A new hydrazone, derived from the antitubercular drug; 
isoniazid was investigated for their topical anti-
inflammatory effect. The test was evaluated by the method 
of xylene induced topical ear edema in mice model. Results 
revealed that the investigated hydrazone has an important 
anti-inflammatory effect. Results obtained in the present 
studies indicate that the hydrazone can at least be a 
potential topical anti-inflammatory agent. 
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